PositiveID’s Caregiver Non-Contact Thermometer Records an Estimated 50 Million Temperatures in 2015
Feb 29, 2016 13:30 pm UTC| Business
DELRAY BEACH, Fla., Feb. 29, 2016 -- PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a life sciences company focused on detection and diagnostics, announced today that its Caregiver® FDA-cleared,...
T-Mobile US, Inc. to Present at the Morgan Stanley Technology, Media and Telecom Conference
Feb 29, 2016 13:30 pm UTC| Business
BELLEVUE, Wash., Feb. 29, 2016 -- J. Braxton Carter, Executive Vice President Chief Financial Officer of T-Mobile US, Inc. (NASDAQ:TMUS) will present at 9:30 a.m. Pacific Standard Time (12:30 p.m. Eastern Standard...
MobileIron Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Feb 29, 2016 13:30 pm UTC| Business
MOUNTAIN VIEW, Calif., Feb. 29, 2016 -- MobileIron, Inc.(NASDAQ:MOBL) today announced that the Compensation Committee of MobileIron’s Board of Directors granted inducement awards toDaniel Fieldsin connection with his...
Study Results: Robotic-Assisted Benign Hysterectomy Yields Better Results in Clinical Outcomes
Feb 29, 2016 13:30 pm UTC| Business
SUNNYVALE, Calif., Feb. 29, 2016 -- Intuitive Surgical, Inc. (Nasdaq:ISRG) today announced the published results from a new study1titled, “Multicenter analysis comparing robotic, open, laparoscopic and vaginal...
Amyris Announces Collaboration Agreement With COFCO Nutrition and Health Research Institute of China
Feb 29, 2016 13:30 pm UTC| Business
EMERYVILLE, Calif., Feb. 29, 2016 -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced a collaboration partnership with COFCO Nutrition and Health Research Institute Co Ltd. ("COFCO NHRI"),...
Feb 29, 2016 13:30 pm UTC| Business
SAN FRANCISCO, Feb. 29, 2016 -- Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm announces the filing of a securities fraud class action lawsuit against BHP Billiton Limited (NYSE:BHP) related to the...
ChemoCentryx to Hold Fourth Quarter 2015 Financial Results Conference Call on Monday, March 14, 2016
Feb 29, 2016 13:30 pm UTC| Business
MOUNTAIN VIEW, Calif., Feb. 29, 2016 -- ChemoCentryx, Inc., (Nasdaq:CCXI), a clinical-stage biopharmaceutical company developing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and...